Using fMRI, the pharmacological effect of cholinesterase inhibitors for Alzheimer’s disease (AD) [12], or that of a peripheral inhibitor of the enzyme catechol-O-methyltransferase for PD [13], have been studied and detected as significant changes of BOLD signal in comparison with placebo. Here, COMT is linked to Alzheimer disease.